期刊文献+

原发性胆汁性肝硬化免疫发病机制的研究进展 被引量:1

Research Progress in Immune pathogenesis of Primary Biliary Cirrhosis
下载PDF
导出
摘要 原发性胆汁性肝硬化(PBC)是一种自身免疫性疾病,以肝内胆管进行性破坏、慢性胆汁淤积为主要特征。PBC的发病机制复杂,涉及遗传易感性、免疫机制、感染因素及化学物质等。了解PBC的发病机制对于采取正确合理的治疗方案,降低其发病率和病死率意义重大。其中免疫机制与机体产生的自身抗体及免疫细胞分泌的多种细胞因子相关。本文就免疫因素在PBC发病机制中的作用进行综述。 Primary biliary cirrhosis (PBC) is considered as a typical autoimmune disease characterized by progressive destruction and chronic cholestasis, and its pathogenesis was complexed, including genetic predisposition,immunologic mechanism,infection, chemical substance and so on. It is important to understand pathogenesis of PBC for treatment plan, degrading disease incidence and death rate of PBC. This article reviewed the immune pathogenesis of PBC.
出处 《医学综述》 2009年第2期185-188,共4页 Medical Recapitulate
关键词 原发性胆汁性肝硬化 自身抗体 细胞因子 Primary biliary cirrhosis Autoantibody Cytokines
  • 相关文献

参考文献22

  • 1Talwalkar JA,Lindor KD. Current and emerging surrogate markers of hepatic fibrosis in Primary biliary cirrhosis [ J ]. Liver Int ,2008, 28(6) :761-763.
  • 2Rigopoulou EI, Davies ET, Bogdanos DP. Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis [ J ]. Liver Int, 2007,27(9) :1226-1231.
  • 3Vleggaar FP,van Buuren HR. No prognostic significance of antimitochondrial antibody profile testingin primary biliary cirrhosis[ J]. Hepatogastroenterology ,2004,51 ( 58 ) :937-940.
  • 4Fukushima N, Nalbandian G, Van De Water J, et al. Characterization of recombinant monoclonal IgA anti-PDC-E2 autoantibodies derived from patients with PBC [J]. Hepatology, 2003,36 ( 21 ) : 1383-1392.
  • 5Yordy JS, Li R, Sementchenko VI, et al. SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion [ J ]. Oncogene ,2004,23 ( 39 ) :6654-6665.
  • 6Nakamura M ,Takii Y, ho M ,et al. Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis [J]. J Autoimmun, 2006,26 ( 2 ) : 138-145.
  • 7杨少奇,王贵杰,杨力,李宁珍,潘月英,郭新宁.肝硬化患者血清瘦素、肿瘤坏死因子α水平及其临床意义[J].实用肝脏病杂志,2006,9(6):330-332. 被引量:2
  • 8Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes[ J]. Trends Immunol,2004,25( 1 ) :4-7.
  • 9Takiguchi J, Ohira H, Rai T, et al. Anti-eosinophil peroxidase antibodies detected in patients with primary biliary cirrhosis[ J]. Hepatol Res ,2005,32( 1 ) :33-37.
  • 10Janka C, Selmie C, Gershwin ME, et al. Small ubiquitin-related modifiers : A novel and independent class of autoantigens in primary biliary cirrhosis[ J]. Hepatology,2005,41 (3) :609-616.

二级参考文献62

  • 1邵杰,魏来,王豪,孙炎.原发性胆汁性肝硬化患者中多核点型抗核抗体的检测[J].世界华人消化杂志,2005,13(12):1478-1481. 被引量:5
  • 2岳凤娥,宋修光,杜文军,张利宁.sTRAIL在肝炎肝硬化和原发性肝癌患者血清中的表达及与肝损伤指标关系的临床研究[J].肿瘤防治杂志,2005,12(4):255-256. 被引量:3
  • 3屠小卿,朱烨,徐玲玲,耿红莲,周琳,刘海英,顾鹏飞,范列英,仲人前.原发性胆汁性肝硬化85例实验室检测指标的分析[J].检验医学,2005,20(6):536-538. 被引量:6
  • 4Moore PA, Belvedere O, Orr A, et al. BlyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science, 1999,285: 260-263.
  • 5Batten M, Groom J, Cachero TG, et al. BAFF mediates survival of peripheral immature B lymphocyte. J Exp Med, 2000, 192: 1453-1466.
  • 6Do RK, Hatada E, Lee H, et al. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med, 2000, 192: 953-964.
  • 7Gross JA, Johnston J, Mudri S, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature, 2000, 404: 995-999.
  • 8Thompson JS, Bixler SA, Qian F, et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.Science, 2001, 293: 2108-2111.
  • 9Holland PM, Abramson RD, Watson R, et al. Detection of specific polymerase chain reaction product by utilizing the 5′- 3′xonoclease to thermos aquaticus DNA polymerase. Proc Natl Acd Sci U S A,1991, 88: 7276-7296.
  • 10Heid CA, Stevens J, Livak KJ, et al. Real time quantitative PCR.Genome Res, 1996, 6: 986-994.

共引文献36

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部